Company news
Transcenta Holding Limited news in 2026
Transcenta Holding Limited's news releases, calls and decks from 2026, newest first.
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
November 5, 2026
Notification letter and request form to non-registered holders
October 30, 2026
Notification letter and reply form to registered holders
October 30, 2026
Form of proxy for the extraordinary general meeting to be held on Thursday, November 19, 2026
October 30, 2026
Notice of extraordinary general meeting
October 30, 2026
(1) Proposed refreshment of scheme mandate limit and service provider sublimit and (2) notice of extraordinary general meeting
October 30, 2026
Update on measures and actions taken in resolving the disclaimer of opinion in the annual report for the year ended December 31, 2025
October 27, 2026
Voluntary announcement-receipt of the first payment in relation to the disposal of CDMO assets
October 20, 2026
Voluntary announcement-business update on the grant of China invention patents related to osemitamab (TST001) and its companion diagnostic antibody
October 11, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
October 7, 2026
Cancellation and grant of award pursuant to the share incentive scheme
September 30, 2026
Notification letter and request form to non-registered holders
September 15, 2026
Notification letter and reply form to registered holders
September 15, 2026
2026 Interim report
September 15, 2026
Transcenta Therapeutics Presents New Data for its Novel LIV1-Targeting ADC TST013 Demonstrating Potent Anti-Tumor Activity in PDX Models of Prostate Cancer and ER Positive /HER2 Negative Breast Cancer
April 23, 2026
Transcenta Therapeutics Appoints Dr. Christopher Hwang as Head of Global Partnerships for HiCB Platform
March 30, 2026
Transcenta Therapeutics to Present at the 36th Annual Oppenheimer Healthcare Life Sciences Conference
February 24, 2026
Decks in 2026
- H1 2026 Earnings Presentation
Earnings · 37 slides · Aug 31, 2026
- FY2025 Earnings Presentation
Earnings · 43 slides · Mar 31, 2026